Immunology

Cancer and stress breakthrough

Stress hormones can trigger the formation of structures that make body tissues more susceptible to metastasis, research has found.

“TB vaccine shrinks mice cancer tumours”

A new study found that a single dose of Bacillus Calmette-Guérin (BCG), the vaccine for tuberculosis (TB), reduced liver tumour burden and extended the survival of mice with liver cancer.

The evolution of cancer

Charlie Swanton outlines the work in cancer research that led to him being awarded a 2024 Louis-Jeantet Prize for translational medicine.

Vaccine effective in preventing typhoid fever

A single dose of the typhoid conjugate vaccine Typbar TCV provides lasting efficacy in preventing typhoid fever in children aged nine months to 12 years old, according to a new study.

Autoimmune diseases revisited: part 3

Is autoimmunity on the increase? Epidemiological evidence. Details of five autoimmune diseases are presented.

Taming the chaotic protein that fuels cancers

MYC is a protein that it is claimed is responsible for making the majority of human cancer cases worse.

Tissue grafts that escape immune system rejection

In a preclinical breakthrough, researchers have developed a technology that may one day eliminate the need for immunosuppressive drugs in transplant patients.

Mechanisms of alarming release discovered

Scientists have demonstrated that important pro-inflammatory mediators are released into the bloodstream through tiny pores in the cell membrane at a very early stage of an immune response.

New vaccine against malaria

The World Health Organization (WHO) has recommended a new vaccine, R21/Matrix-M, for the prevention of malaria in children.

Why didn’t people in the US get COVID-19 boosters?

More than 80% of the people in the US who were eligible to receive a COVID-19 booster last autumn did not have the jab.

Suppressing autoimmunity

Researchers have uncovered new details about how the immune system prevents the production of antibodies that can recognise and damage healthy tissues.

Top